AOR ORTHO GLUCOFORMIN 90 CAPS

DETAILS

Tetrahydrocurcumin (Curcumin C3 Reduct™) is a patented reduced form (metabolite) of curcumin and is colourless, so don’t be alarmed if you don’t see that rich orange hue you may be used to. Curcumin converts enzymatically into C3, inside the intestine before getting absorbed in the body. This reduced form has a very potent antioxidant effect.

Amla has a very high ORAC score (Oxygen Radical Absorbance Capacity) which measures the total antioxidant power it has to “mop up” toxins.

This amla extract called Saberry™ is still a rich source of vitamin C, but it is uniquely standardized to contain 10% β -Glucogallin, and 3% gallic acid.

These are two important and well-researched bioactive molecules related to some of the cardiovascular and blood sugar management properties. Together the combined antioxidant effect can be helpful in cardiovascular and metabolic disorders.

AOR Advantage
AOR Ortho Glucoformin is the first product of its kind combining these elite ingredients together in one formula.

Adults (18 years and over) – Take one capsule with each meal three times a day, or as directed by a health care professional. Take 2 hours before or after taking other medications. Do not exceed daily dose unless instructed by a healthcare practitioner.

Do not use with antihypertensive medication if you are pregnant or breastfeeding.

Consult a health care practitioner if you have uncontrolled cardiovascular disease or when using this product consult a healthcare practitioner if:

• you have or develop abdominal pain, nausea, fever or vomiting.
• you have uncontrolled cardiovascular disease or advanced atherosclerosis (e.g., history of stroke, myocardial infarction, life-threatening arrhythmia, arterial fibrillation, or coronary revascularization, unstable angina, congestive heart failure)
• you have high renal dysfunction, advanced liver function disorder, or anemia.
• you have type I diabetes, chronic gastrointestinal diseases, severe immune deficiency, or thyroid disorder.
• you are currently on lipid lowering therapy, systemic or topical corticosteroid therapy.
• symptoms persist or worsen.
• for use beyond 3 months